Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Synthesis  





2 References  





3 Further reading  














Chlormezanone






Cymraeg
فارسی

Српски / srpski
Srpskohrvatski / српскохрватски
Svenska
Tiếng Vit
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Chlormezanone
Skeletal formula of chlormezanone
Space-filling model of the chlormezanone molecule
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Elimination half-life40.5 hours
Identifiers
  • 2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one

CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.001.190 Edit this at Wikidata
Chemical and physical data
FormulaC11H12ClNO3S
Molar mass273.73 g·mol−1
3D model (JSmol)
  • O=S1(CCC(N(C)C1C2=CC=C(C=C2)Cl)=O)=O

  • InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3 checkY

  • Key:WEQAYVWKMWHEJO-UHFFFAOYSA-N checkY

 ☒NcheckY (what is this?)  (verify)

Chlormezanone (marketed under the brandname TrancopalorFenaprim) is a drug used as an anxiolytic and a muscle relaxant.[1]

Its use was discontinued in many countries in 1996 due to rare but serious cases of toxic epidermal necrolysis.[2]

Synthesis[edit]

Chlormezanone synthesis[3][4]

References[edit]

  1. ^ Turner P, Volan G, Wiseman H (1997). Drugs Handbook. UK: Palgrave Macmillan. p. 20. ISBN 978-1-349-13937-8.
  • ^ Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T (February 2018). "Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis". Clinical Reviews in Allergy & Immunology. 54 (1): 147–176. doi:10.1007/s12016-017-8654-z. PMID 29188475. S2CID 46796285.
  • ^ US 3082209, Surrey AR, "4-metathiazanone derivatives and their preparation", issued 1958, assigned to Sterling Drug Inc. 
  • ^ Surrey AR, Webb WG, Gesler RM (1958). "Central Nervous System Depressants. The Preparation of Some 2-Aryl-4-metathiazanones". Journal of the American Chemical Society. 80 (13): 3469–3471. doi:10.1021/ja01546a065.
  • Further reading[edit]

    • Wollina U, Hipler UC, Seeling A, Oelschlager H (2005). "Investigations of interactions of chlormezanone racemate and its enantiomers on human keratinocytes and human leucoytes in vitro". Skin Pharmacology and Physiology. 18 (3): 132–138. doi:10.1159/000084910. PMID 15897685. S2CID 36642315.
  • Seeling A, Oelschläger H, Rothley D (April 2000). "[Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone]". Die Pharmazie. 55 (4): 293–296. PMID 10798243.
  • Oelschläger H, Klinger W, Rothley D, Seeling A, Bockhard H, Hofmann B, et al. (September 1998). "[Cleavage and biotransformation of the central muscle relaxant chlormezanone]". Die Pharmazie. 53 (9): 620–624. PMID 9770210.
  • Gautier V, Vinçon G, Demotes-Mainard F, Albin H (1990). "[Pharmacokinetics of chlormezanone in healthy volunteers]". Therapie. 45 (4): 315–319. PMID 2399514.
  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Chlormezanone&oldid=1191967553"

    Categories: 
    Muscle relaxants
    Sulfones
    Chloroarenes
    Hepatotoxins
    Withdrawn drugs
    GABAA receptor positive allosteric modulators
    Musculoskeletal system drug stubs
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
    Drugs with non-standard legal status
    Articles with changed EBI identifier
    ECHA InfoCard ID from Wikidata
    Drugboxes which contain changes to verified fields
    Drugboxes which contain changes to watched fields
    All stub articles
     



    This page was last edited on 26 December 2023, at 21:42 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki